Shares of Pluri Inc. (NASDAQ:PLUR – Get Free Report) were down 4.4% on Tuesday . The company traded as low as $4.30 and last traded at $4.30. Approximately 28,199 shares changed hands during mid-day trading, an increase of 89% from the average daily volume of 14,909 shares. The stock had previously closed at $4.50.
Pluri Stock Performance
The company has a market cap of $23.90 million, a PE ratio of -0.71 and a beta of 1.67. The company has a 50-day moving average of $4.62 and a 200-day moving average of $5.02. The company has a quick ratio of 5.90, a current ratio of 5.90 and a debt-to-equity ratio of 4.44.
Pluri (NASDAQ:PLUR – Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($1.08) earnings per share (EPS) for the quarter. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%. The firm had revenue of $0.33 million for the quarter.
Pluri Company Profile
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Recommended Stories
- Five stocks we like better than Pluri
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Canada Bond Market Holiday: How to Invest and Trade
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
